DSM is seeking acquisitions in the $0.5-1bn range to bolster its life sciences and materials businesses. The company also plans strategic divestments, said chief executive officer, Feike Sijbesma.
Forbes
Thursday 14 February 2008
DSM to buy and sell
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment